ResMed Statistics

Total Valuation

ResMed has a market cap or net worth of MXN 652.17 billion. The enterprise value is 642.27 billion.

Market Cap	652.17B
Enterprise Value	642.27B

Important Dates

The next estimated earnings date is Thursday, April 23, 2026.

Earnings Date	Apr 23, 2026
Ex-Dividend Date	Feb 12, 2026

Share Statistics

Current Share Class	145.75M
Shares Outstanding	n/a
Shares Change (YoY)	-0.43%
Shares Change (QoQ)	-0.36%
Owned by Insiders (%)	0.52%
Owned by Institutions (%)	74.53%
Float	144.79M

Valuation Ratios

The trailing PE ratio is 24.38 and the forward PE ratio is 22.14.

PE Ratio	24.38
Forward PE	22.14
PS Ratio	6.71
PB Ratio	5.73
P/TBV Ratio	12.73
P/FCF Ratio	20.22
P/OCF Ratio	18.92
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.86, with an EV/FCF ratio of 19.91.

EV / Earnings	24.01
EV / Sales	6.84
EV / EBITDA	17.86
EV / EBIT	19.96
EV / FCF	19.91

Financial Position

The company has a current ratio of 3.06, with a Debt / Equity ratio of 0.13.

Current Ratio	3.06
Quick Ratio	1.97
Debt / Equity	0.13
Debt / EBITDA	0.41
Debt / FCF	0.47
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 25.68% and return on invested capital (ROIC) is 26.60%.

Return on Equity (ROE)	25.68%
Return on Assets (ROA)	14.75%
Return on Invested Capital (ROIC)	26.60%
Return on Capital Employed (ROCE)	25.44%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	9.17M
Profits Per Employee	2.52M
Employee Count	10,600
Asset Turnover	0.69
Inventory Turnover	2.15

Taxes

In the past 12 months, ResMed has paid 5.99 billion in taxes.

Income Tax	5.99B
Effective Tax Rate	18.30%

Stock Price Statistics

The stock price has decreased by -9.11% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-9.11%
50-Day Moving Average	4,401.64
200-Day Moving Average	n/a
Relative Strength Index (RSI)	48.96
Average Volume (20 Days)	389

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	9.67

Income Statement

In the last 12 months, ResMed had revenue of MXN 97.18 billion and earned 26.75 billion in profits. Earnings per share was 182.03.

Revenue	97.18B
Gross Profit	59.74B
Operating Income	33.22B
Pretax Income	32.74B
Net Income	26.75B
EBITDA	36.46B
EBIT	33.22B
Earnings Per Share (EPS)	182.03

Full Income Statement

Balance Sheet

The company has 25.51 billion in cash and 15.26 billion in debt, giving a net cash position of 10.25 billion.

Cash & Cash Equivalents	25.51B
Total Debt	15.26B
Net Cash	10.25B
Net Cash Per Share	n/a
Equity (Book Value)	113.80B
Book Value Per Share	781.23
Working Capital	46.28B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 34.47 billion and capital expenditures -2.21 billion, giving a free cash flow of 32.25 billion.

Operating Cash Flow	34.47B
Capital Expenditures	-2.21B
Free Cash Flow	32.25B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 61.47%, with operating and profit margins of 34.19% and 27.53%.

Gross Margin	61.47%
Operating Margin	34.19%
Pretax Margin	33.69%
Profit Margin	27.53%
EBITDA Margin	37.51%
EBIT Margin	34.19%
FCF Margin	33.19%

Dividends & Yields

This stock pays an annual dividend of 42.88, which amounts to a dividend yield of 0.96%.

Dividend Per Share	42.88
Dividend Yield	0.96%
Dividend Growth (YoY)	8.01%
Years of Dividend Growth	2
Payout Ratio	23.56%
Buyback Yield	0.43%
Shareholder Yield	1.39%
Earnings Yield	4.10%
FCF Yield	4.95%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ResMed has an Altman Z-Score of 12.89 and a Piotroski F-Score of 6.

Altman Z-Score	12.89
Piotroski F-Score	6